Anne O'donnell

Critical Care Medicine Washington, DC Female
NPI: 1629066899
Total Payments
$128,159
2024 Payments
$2,325
Companies
24
Transactions
102
Medicare Patients
4,157
Medicare Billing
$412,362

Payment Breakdown by Category

Consulting$77,162 (60.2%)
Other$33,389 (26.1%)
Travel$12,256 (9.6%)
Food & Beverage$5,137 (4.0%)
Research$150.00 (0.1%)
Education$65.10 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $77,162 22 60.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $33,389 8 26.1%
Travel and Lodging $12,256 16 9.6%
Food and Beverage $5,137 52 4.0%
Unspecified $150.00 1 0.1%
Education $65.10 3 0.1%

Payments by Type

General
$128,009
101 transactions
Research
$150.00
1 transactions

Top Paying Companies

Company Total Records Latest Year
Xellia Pharmaceuticals $35,347 7 $0 (2018)
Boehringer Ingelheim International GmbH $22,055 11 $0 (2024)
Insmed, Inc. $19,945 31 $0 (2023)
Bayer HealthCare Pharmaceuticals Inc. $18,222 3 $0 (2019)
Grifols Shared Services North America, Inc. $12,843 11 $0 (2017)
Merck Sharp & Dohme Corporation $5,426 5 $0 (2019)
Electromed, Inc. $3,991 3 $0 (2019)
Grifols USA, LLC $3,345 5 $0 (2017)
Paratek Pharmaceuticals, Inc. $2,476 3 $0 (2021)
AstraZeneca UK Limited $1,945 1 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,325 7 Boehringer Ingelheim International GmbH ($2,223)
2023 $1,511 3 Boehringer Ingelheim International GmbH ($1,302)
2022 $13,879 13 Boehringer Ingelheim International GmbH ($8,730)
2021 $14,740 9 Boehringer Ingelheim International GmbH ($9,800)
2020 $13,947 20 Insmed, Inc. ($11,842)
2019 $8,715 14 Merck Sharp & Dohme Corporation ($5,426)
2018 $37,501 12 Xellia Pharmaceuticals ($35,347)
2017 $35,541 24 Bayer HealthCare Pharmaceuticals Inc. ($18,100)

All Payment Transactions

102 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
12/08/2024 Zambon USA Ltd. — Consulting Fee In-kind items and services $31.89 General
11/21/2024 Boehringer Ingelheim International GmbH — Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $1,689.30 General
09/26/2024 Boehringer Ingelheim International GmbH — Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $159.31 General
07/24/2024 Avadel CNS Pharmaceuticals, LLC LUMRYZ (Drug) Food and Beverage In-kind items and services $70.67 General
Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY
06/09/2024 Boehringer Ingelheim International GmbH OFEV (Drug) Food and Beverage In-kind items and services $80.72 General
Category: RESPIRATORY
06/09/2024 Boehringer Ingelheim International GmbH OFEV (Drug) Food and Beverage In-kind items and services $54.54 General
Category: RESPIRATORY
05/01/2024 Boehringer Ingelheim International GmbH — Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $238.96 General
04/11/2023 Boehringer Ingelheim International GmbH — Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $1,301.70 General
03/15/2023 GENZYME CORPORATION — Food and Beverage In-kind items and services $92.07 General
01/18/2023 Insmed, Inc. — Food and Beverage In-kind items and services $117.10 General
11/22/2022 Insmed, Inc. — Consulting Fee Cash or cash equivalent $4,270.00 General
11/16/2022 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $98.18 General
Category: Respiratory
11/08/2022 Boehringer Ingelheim International GmbH OFEV (Drug) Consulting Fee Cash or cash equivalent $3,395.00 General
Category: RESPIRATORY
10/15/2022 Insmed, Inc. — Food and Beverage In-kind items and services $72.71 General
10/15/2022 Insmed, Inc. — Food and Beverage In-kind items and services $72.71 General
10/15/2022 Insmed, Inc. — Food and Beverage In-kind items and services $20.58 General
10/15/2022 Insmed, Inc. — Food and Beverage In-kind items and services $20.58 General
09/21/2022 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $107.10 General
Category: Immunology
07/20/2022 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $109.28 General
Category: IMMUNOLOGY
06/13/2022 Boehringer Ingelheim International GmbH OFEV (Drug) Consulting Fee Cash or cash equivalent $5,335.00 General
Category: RESPIRATORY
06/01/2022 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $105.28 General
Category: Respiratory
05/15/2022 Insmed, Inc. Arikayce (Drug) — In-kind items and services $150.00 Research
Category: Respiratory
05/02/2022 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $122.93 General
Category: Respiratory
11/23/2021 Insmed, Inc. — Consulting Fee In-kind items and services $2,440.00 General
11/13/2021 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Consulting Fee Cash or cash equivalent $2,220.00 General
Category: ANTIBIOTIC
123…5»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 17 1,023 1,240 $329,166 $110,187
2022 13 801 935 $245,996 $84,030
2021 22 1,240 1,440 $339,104 $118,679
2020 23 1,093 1,266 $307,270 $99,466
Total Patients
4,157
Total Services
4,881
Medicare Billing
$412,362
Procedure Codes
75

All Medicare Procedures & Services

75 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 222 361 $104,671 $40,294 38.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 166 201 $41,515 $15,239 36.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 67 67 $27,087 $8,631 31.9%
99291 Critical care, first 30-74 minutes Facility 2023 33 41 $25,174 $7,573 30.1%
94729 Test to examine how well the lungs exchange gases Office 2023 113 114 $24,236 $5,809 24.0%
94726 Test to determine lung volumes using sensors Office 2023 105 106 $21,644 $5,170 23.9%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 31 48 $12,333 $5,086 41.2%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 24 24 $12,272 $4,450 36.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 19 22 $8,478 $3,109 36.7%
94375 Test to measure rate of airflow Office 2023 87 89 $9,634 $3,044 31.6%
94621 Test for exercise-induced heart and lung stress Office 2023 19 21 $9,240 $2,698 29.2%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 23 23 $6,272 $2,269 36.2%
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation Office 2023 25 25 $12,437 $1,976 15.9%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 15 24 $4,188 $1,691 40.4%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Office 2023 43 43 $7,181 $1,455 20.3%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 15 15 $1,860 $1,137 61.1%
G0008 Administration of influenza virus vaccine Office 2023 16 16 $944.00 $554.08 58.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 185 266 $70,702 $29,745 42.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 174 205 $38,170 $15,927 41.7%
99291 Critical care, first 30-74 minutes Facility 2022 48 54 $33,156 $10,582 31.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 48 48 $19,248 $6,899 35.8%
94729 Test to examine how well the lungs exchange gases Office 2022 77 78 $18,408 $3,856 20.9%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 26 39 $9,750 $3,581 36.7%
94726 Test to determine lung volumes using sensors Office 2022 73 74 $17,390 $3,506 20.2%
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation Office 2022 26 26 $12,494 $2,279 18.2%
123»

About Anne O'donnell

Anne O'donnell is a Critical Care Medicine healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1629066899.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anne O'donnell has received a total of $128,159 in payments from pharmaceutical and medical device companies, with $2,325 received in 2024. These payments were reported across 102 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($77,162).

As a Medicare-enrolled provider, O'donnell has provided services to 4,157 Medicare beneficiaries, totaling 4,881 services with total Medicare billing of $412,362. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.

Practice Information

  • Specialty Critical Care Medicine
  • Other Specialties Pulmonary Disease
  • Location Washington, DC
  • Active Since 10/11/2005
  • Last Updated 03/14/2012
  • Taxonomy Code 207RC0200X
  • Entity Type Individual
  • NPI Number 1629066899

Products in Payments

  • Cipro (Drug) $18,100
  • OFEV (Drug) $13,715
  • SMARTVEST (Device) $3,991
  • NUZYRA (Drug) $2,476
  • FASENRA (Drug) $2,062
  • Arikayce (Drug) $1,067
  • NO_PRODUCT (Drug) $600.00
  • QUINSAIR (Drug) $226.70
  • Esbriet (Biological) $123.27
  • Adempas (Drug) $122.23
  • Letairis (Drug) $118.15
  • REMODULIN (Drug) $110.45
  • NUCALA (Biological) $109.28
  • RUCONEST (Biological) $108.68
  • UPTRAVI (Drug) $107.68
  • DUPIXENT (Biological) $107.10
  • DUPIXENT (Drug) $102.46
  • FASENRA (Biological) $98.18
  • Yupelri (Drug) $95.09
  • LUMRYZ (Drug) $70.67

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Critical Care Medicine Doctors in Washington

Jonathan Chow, M.d, M.D

Critical Care Medicine — Payments: $328,413

Critical Care Medicine $328,413

Eric Anderson

Critical Care Medicine — Payments: $177,372

Critical Care Medicine $177,372

Tunay Kuru, Md, MD

Critical Care Medicine — Payments: $135,801

Critical Care Medicine $135,801

Dr. Andrew Lerner, Md, MD

Critical Care Medicine — Payments: $18,342

Critical Care Medicine $18,342

Dr. Joseph Parker, M.d, M.D

Critical Care Medicine — Payments: $15,513

Critical Care Medicine $15,513

Dr. Vivek Jain, Md, MD

Critical Care Medicine — Payments: $12,900

Critical Care Medicine $12,900